230 related articles for article (PubMed ID: 8651708)
21. Modulation of cytochrome P450 gene expression and arachidonic acid metabolism during isoproterenol-induced cardiac hypertrophy in rats.
Zordoky BN; Aboutabl ME; El-Kadi AO
Drug Metab Dispos; 2008 Nov; 36(11):2277-86. PubMed ID: 18725507
[TBL] [Abstract][Full Text] [Related]
22. Acute doxorubicin toxicity differentially alters cytochrome P450 expression and arachidonic acid metabolism in rat kidney and liver.
Zordoky BN; Anwar-Mohamed A; Aboutabl ME; El-Kadi AO
Drug Metab Dispos; 2011 Aug; 39(8):1440-50. PubMed ID: 21571947
[TBL] [Abstract][Full Text] [Related]
23. Roles of human hepatic cytochrome P450s 2C9 and 3A4 in the metabolic activation of diclofenac.
Tang W; Stearns RA; Wang RW; Chiu SH; Baillie TA
Chem Res Toxicol; 1999 Feb; 12(2):192-9. PubMed ID: 10027798
[TBL] [Abstract][Full Text] [Related]
24. Molecular cloning, enzymatic characterization, developmental expression, and cellular localization of a mouse cytochrome P450 highly expressed in kidney.
Ma J; Qu W; Scarborough PE; Tomer KB; Moomaw CR; Maronpot R; Davis LS; Breyer MD; Zeldin DC
J Biol Chem; 1999 Jun; 274(25):17777-88. PubMed ID: 10364221
[TBL] [Abstract][Full Text] [Related]
25. Endogenous epoxyeicosatrienoic acids. Cytochrome P-450 controlled stereoselectivity of the hepatic arachidonic acid epoxygenase.
Karara A; Dishman E; Blair I; Falck JR; Capdevila JH
J Biol Chem; 1989 Nov; 264(33):19822-7. PubMed ID: 2584196
[TBL] [Abstract][Full Text] [Related]
26. Characterization of human liver and kidney cytochrome P-450-dependent arachidonic acid epoxygenase.
Abraham NG; Davis K; Schwartzman ML
Adv Prostaglandin Thromboxane Leukot Res; 1989; 19():347-50. PubMed ID: 2526497
[No Abstract] [Full Text] [Related]
27. Cytochrome P450-dependent transformations of 15R- and 15S-hydroperoxyeicosatetraenoic acids: stereoselective formation of epoxy alcohol products.
Chang MS; Boeglin WE; Guengerich FP; Brash AR
Biochemistry; 1996 Jan; 35(2):464-71. PubMed ID: 8555216
[TBL] [Abstract][Full Text] [Related]
28. Purification and properties of a cytochrome P450 arachidonic acid epoxygenase from rabbit renal cortex.
Laethem RM; Laethem CL; Koop DR
J Biol Chem; 1992 Mar; 267(8):5552-9. PubMed ID: 1544930
[TBL] [Abstract][Full Text] [Related]
29. Cytochrome P-450 arachidonic acid epoxygenase. Regulatory control of the renal epoxygenase by dietary salt loading.
Capdevila JH; Wei S; Yan J; Karara A; Jacobson HR; Falck JR; Guengerich FP; DuBois RN
J Biol Chem; 1992 Oct; 267(30):21720-6. PubMed ID: 1400482
[TBL] [Abstract][Full Text] [Related]
30. Molecular, enzymatic, and regulatory characterization of rat kidney cytochromes P450 4A2 and 4A3.
Helvig C; Dishman E; Capdevila JH
Biochemistry; 1998 Sep; 37(36):12546-58. PubMed ID: 9730827
[TBL] [Abstract][Full Text] [Related]
31. Induction of renal cytochrome P450 arachidonic acid epoxygenase activity by dietary gamma-linolenic acid.
Yu Z; Ng VY; Su P; Engler MM; Engler MB; Huang Y; Lin E; Kroetz DL
J Pharmacol Exp Ther; 2006 May; 317(2):732-8. PubMed ID: 16421287
[TBL] [Abstract][Full Text] [Related]
32. The roles of CYP450 epoxygenases and metabolites, epoxyeicosatrienoic acids, in cardiovascular and malignant diseases.
Xu X; Zhang XA; Wang DW
Adv Drug Deliv Rev; 2011 Jul; 63(8):597-609. PubMed ID: 21477627
[TBL] [Abstract][Full Text] [Related]
33. Identification of human cytochrome P450 isozymes responsible for the in vitro oxidative metabolism of finasteride.
Huskey SW; Dean DC; Miller RR; Rasmusson GH; Chiu SH
Drug Metab Dispos; 1995 Oct; 23(10):1126-35. PubMed ID: 8654202
[TBL] [Abstract][Full Text] [Related]
34. Molecular cloning, expression, and functional significance of a cytochrome P450 highly expressed in rat heart myocytes.
Wu S; Chen W; Murphy E; Gabel S; Tomer KB; Foley J; Steenbergen C; Falck JR; Moomaw CR; Zeldin DC
J Biol Chem; 1997 May; 272(19):12551-9. PubMed ID: 9139707
[TBL] [Abstract][Full Text] [Related]
35. Identification and characterization of a cDNA encoding cytochrome P450 3A from the fresh water teleost medaka (Oryzias latipes).
Kullman SW; Hamm JT; Hinton DE
Arch Biochem Biophys; 2000 Aug; 380(1):29-38. PubMed ID: 10900129
[TBL] [Abstract][Full Text] [Related]
36. Differences in cytochrome P450-mediated biotransformation of 1,2-dichlorobenzene by rat and man: implications for human risk assessment.
Hissink AM; Oudshoorn MJ; Van Ommen B; Haenen GR; Van Bladeren PJ
Chem Res Toxicol; 1996 Dec; 9(8):1249-56. PubMed ID: 8951226
[TBL] [Abstract][Full Text] [Related]
37. Cytochrome P-450 metabolites of arachidonic acid: implications for blood pressure regulation.
Carroll MA; Escalante B; McGiff JC
Pol J Pharmacol Pharm; 1990; 42(3):191-201. PubMed ID: 2124686
[TBL] [Abstract][Full Text] [Related]
38. Influence of inflammation on cardiovascular protective effects of cytochrome P450 epoxygenase-derived epoxyeicosatrienoic acids.
Shahabi P; Siest G; Visvikis-siest S
Drug Metab Rev; 2014 Feb; 46(1):33-56. PubMed ID: 24040964
[TBL] [Abstract][Full Text] [Related]
39. Cytochrome P-450 enzyme-specific control of the regio- and enantiofacial selectivity of the microsomal arachidonic acid epoxygenase.
Capdevila JH; Karara A; Waxman DJ; Martin MV; Falck JR; Guenguerich FP
J Biol Chem; 1990 Jul; 265(19):10865-71. PubMed ID: 2358445
[TBL] [Abstract][Full Text] [Related]
40. The "albumin effect" and in vitro-in vivo extrapolation: sequestration of long-chain unsaturated fatty acids enhances phenytoin hydroxylation by human liver microsomal and recombinant cytochrome P450 2C9.
Rowland A; Elliot DJ; Knights KM; Mackenzie PI; Miners JO
Drug Metab Dispos; 2008 May; 36(5):870-7. PubMed ID: 18256202
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
